Psyence Biomedical (Psyence Biomedical) Days Payable : 0.00 (As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Days Payable?

Psyence Biomedical's average Accounts Payable for the six months ended in Mar. 2023 was $0.82 Mil. Psyence Biomedical's Cost of Goods Sold for the six months ended in Mar. 2023 was $0.00 Mil.

The historical rank and industry rank for Psyence Biomedical's Days Payable or its related term are showing as below:

PBM's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 147.95
* Ranked among companies with meaningful Days Payable only.

Psyence Biomedical's Days Payable stayed the same from Mar. 2021 (0.00) to Mar. 2023 (0.00).

Psyence Biomedical Days Payable Historical Data

The historical data trend for Psyence Biomedical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Days Payable Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Days Payable

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Days Payable	-	-	-

Competitive Comparison of Psyence Biomedical's Days Payable

For the Biotechnology subindustry, Psyence Biomedical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Psyence Biomedical's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Days Payable distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Days Payable falls into.

Psyence Biomedical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Psyence Biomedical's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

	Days Payable (A: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2022 )	+	Accounts Payable (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (0.036	+	1.61)	/	2 )	/	0	*	365
=	0.823					/	0	*	365
=	N/A

Psyence Biomedical's Days Payable for the quarter that ended in Mar. 2023 is calculated as:

	Days Payable (Q: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2022 )	+	Accounts Payable (Q: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2023 )	*	Days in Period
=	( (0.036	+	1.61)	/	2 )	/	0	*	365 / 2
=	0.823					/	0	*	365 / 2
=	N/A

Psyence Biomedical Days Payable Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024